Literature DB >> 1819157

[Saccharomyces boulardii fungemia. Apropos of a case].

P Zunic, J Lacotte, M Pegoix, G Buteux, G Leroy, B Mosquet, M Moulin.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1819157

Source DB:  PubMed          Journal:  Therapie        ISSN： 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  6 in total

Review 1.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

Review 2.  Probiotics for antibiotic-associated diarrhea: do we have a verdict?

Authors:  Iyad Issa; Rami Moucari
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).

Authors:  M J McCullough; K V Clemons; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 4.  Saccharomyces boulardii in childhood.

Authors:  Yvan Vandenplas; Oscar Brunser; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2008-12-19       Impact factor: 3.183

Review 5.  Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism.

Authors:  Marco Cassone; Pietro Serra; Francesca Mondello; Antonietta Girolamo; Sandro Scafetti; Eleonora Pistella; Mario Venditti
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

6.  Disseminated infection with Saccharomyces kluyveri in a patient with AIDS.

Authors:  M Pynka; A Wnuk; D Bander; M Syczewska; A Boroń; B Prost; S Wrzecion
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.